Ε-Poly-l-lysine-hydroxyphenyl Propionic Acid/il-4 Composite Hydrogels with Inflammation Regulation and Antibacterial Activity for Improving Integration Stability of Soft Tissues and Orthopedic Implants.
Chaoqun You,Jiashi Cao,Yan Du,Cheng Peng,Linfei Cheng,Jiaji Ren,Wanli Zhang,Heng Zheng,Kai Guo,Xin Gao,Fei Zhang,Jing Wang,Hong Li,Tielong Liu
DOI: https://doi.org/10.1016/j.ijbiomac.2023.127937
IF: 8.2
2023-01-01
International Journal of Biological Macromolecules
Abstract:The failure of orthopedic implants is usually caused by inflammation, poor tissue integration, and infection, which can lead to pain, limited mobility, dysfunction of patients. This may require additional surgical interventions, such as removal, replacement, or repair of implants, as well as related treatment measures such as antibiotic therapy, physical therapy. Here, an injectable hydrogel carrier was developed for the steady release of inflammatory regulators to reduce the surface tissue inflammatory response of orthopedic implants and induce soft tissue regeneration, ultimately achieving the promotion of implants stability. The hydrogels carrier was prepared by hydroxyphenyl propionic acid-modified ε-Poly-l-lysine (EPA), hydrogen peroxide and horseradish peroxidase, which showed antibacterial bioactive and stable factor release ability. Due to the introduction of IL-4, EPA@IL-4 hydrogels showed good inflammatory regulation. EPA@IL-4 hydrogels regulated the differentiation of macrophages into M2 in inflammatory environment in vitro, and promoted endothelial cells to show a more obvious trend of tube formation. The composite hydrogels reduced the inflammation on the surface of the implants in vivo, induced local endothelial cell angiogenesis, and had more collagen deposition and new granulation tissue. Therefore, EPA hydrogels based on IL-4 release are promising candidates for promoting of implants surface anti-inflammatory, soft tissue regeneration, and anti-infection.